Indian stock markets are expected to open on a cautious note on Tuesday, April 9, following a sharp rebound on Monday. The Sensex surged 1,089 points in the previous session, recovering from its steepest fall in 10 months. However, early indicators show a mixed outlook as Gift Nifty was down 0.28%% at 22,455 as of 8:25 AM, pointing to a soft start.
Several stocks are likely to be in focus today due to sectoral movements, corporate announcements and global developments.
Key Stocks to Watch on April 9
Oil & Gas, Paint Companies
-
OMCs (BPCL, ONGC, OIL) and paint manufacturers may be impacted as US Crude (WTI) fell 4% to a four-year low. Brent crude is nearing the $60/bbl mark, potentially affecting input costs and margins.
BPCL
-
Signed a joint venture agreement with Sembcorp Green Hydrogen India for renewable energy and green hydrogen projects.
IRB Infrastructure
-
Reported a 15.8% YoY rise in toll collections for March 2025. The company expects the growth momentum to continue.
HUDCO
-
Received approval from the Finance Ministry to issue capital gain bonds under Section 54EC for infrastructure financing.
Phoenix Mills
-
Consumption across all operational malls rose 15% year-on-year in Q4.
Senco Gold
-
Reported 23% revenue growth in Q4, supported by an 18.4% increase in same-store sales.
Cochin Shipyard
-
Signed an MoU with Drydocks World to develop ship repair clusters.
Signature Global
-
Exceeded its FY25 pre-sales guidance, with a 42% year-on-year increase in pre-sales.
Home First Finance
-
Launched a ₹1,250 crore Qualified Institutional Placement (QIP). Sources indicate a price range of ₹968–₹988 per share.
Symphony
-
Board to consider the divestment of its Australian and Mexican subsidiaries.
Shyam Metalics
-
Reported 13% YoY growth in stainless steel volumes for March. Average realization for aluminium foil also rose 14% YoY.
Concord Biotech
-
Received final approval from the US FDA to market Teriflunomide, a drug used to treat multiple sclerosis, in the US. The market size is estimated at $402 million.
Pharma Sector
-
US President reiterated plans to impose tariffs on Chinese goods, including pharmaceuticals. An official announcement is expected soon.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
